史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症及生物制剂治疗：一例报告
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.
作者信息
Chong Ian, Chao Alice
机构信息
Attending Physician in Emergency Medicine at the Zion Medical Center in San Diego, CA.
Attending Physician in Emergency Medicine at the Santa Clara Medical Center in CA.
出版信息
Perm J. 2017;21:16-060. doi: 10.7812/TPP/16-060.
Abstract
INTRODUCTION
One of the most dangerous dermatologic emergencies is Stevens-Johnson Syndrome (SJS)/toxic epidermal necrolysis (TEN). Although a rare disease, it can often lead to significant mortality.
CASE PRESENTATION
In this case report, we present a 77-year-old man who developed a sloughing rash that was secondary to a nonsteroidal anti-inflammatory drug. In addition to the recommended supportive care, the patient was treated with etanercept, a new, less commonly used intervention.
DISCUSSION
We provide a brief review of SJS/TEN. Nonsteroidal anti-inflammatory drugs are a rare cause of SJS/TEN, and additionally, the use of biologics is a novel treatment modality for SJS/TEN.
摘要
引言
史蒂文斯-约翰逊综合征（SJS）/中毒性表皮坏死松解症（TEN）是最危险的皮肤科急症之一。尽管是一种罕见疾病，但它常常会导致较高的死亡率。
病例报告
在本病例报告中，我们介绍了一名77岁男性，他因非甾体抗炎药引发了脱皮性皮疹。除了推荐的支持性治疗外，该患者还接受了依那西普治疗，这是一种新的、较少使用的干预措施。
讨论
我们简要回顾了SJS/TEN。非甾体抗炎药是SJS/TEN的罕见病因，此外，生物制剂的使用是SJS/TEN的一种新型治疗方式。
相似文献
1
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症及生物制剂治疗：一例报告
Perm J. 2017;21:16-060. doi: 10.7812/TPP/16-060.
2
Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.依那西普治疗儿童史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
J Cutan Med Surg. 2018 Sep/Oct;22(5):514-515. doi: 10.1177/1203475418758989. Epub 2018 Feb 9.
3
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症：一篇简要综述，全面总结治疗干预措施，重点强调支持性措施
Adv Ther. 2017 Jun;34(6):1235-1244. doi: 10.1007/s12325-017-0530-y. Epub 2017 Apr 24.
4
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的治疗：病例报告及文献复习。
J Drugs Dermatol. 2023 Nov 1;22(11):e24-e28. doi: 10.36849/JDD.6999.
5
Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.儿科 SJS/TEN 经地塞米松、环孢素和依那西普联合治疗得到控制。
J Cutan Med Surg. 2019 Sep/Oct;23(5):547-550. doi: 10.1177/1203475419861078.
6
The use of etanercept for treatment of toxic epidermal necrolysis when toxic shock syndrome is in the differential.在鉴别中毒性休克综合征时，使用依那西普治疗中毒性表皮坏死松解症。
Dermatol Ther. 2018 Sep;31(5):e12684. doi: 10.1111/dth.12684. Epub 2018 Sep 2.
7
A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With Biologic for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.生物制剂单药和联合治疗 Stevens-Johnson 综合征和中毒性表皮坏死松解症的疗效和安全性的系统评价。
J Cutan Med Surg. 2021 Nov-Dec;25(6):598-615. doi: 10.1177/1203475421993779. Epub 2021 Feb 25.
8
Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.环孢素在 Stevens-Johnson 综合征和中毒性表皮坏死松解症中的疗效和安全性。
Dermatol Ther. 2019 Jan;32(1):e12758. doi: 10.1111/dth.12758. Epub 2018 Oct 30.
9
Rapid remission of Stevens-Johnson syndrome by combination therapy using etanercept and intravenous immunoglobulin and a review of the literature.采用依那西普联合静脉注射免疫球蛋白治疗史蒂文斯-约翰逊综合征快速缓解：文献复习
Dermatol Ther. 2019 Jul;32(4):e12832. doi: 10.1111/dth.12832. Epub 2019 Feb 21.
10
Successful treatment of interstitial lung disease related to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review.成功治疗依那西普相关史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠性间质性肺病：病例报告及文献复习。
J Dermatol. 2019 Nov;46(11):1035-1038. doi: 10.1111/1346-8138.15058. Epub 2019 Aug 22.
引用本文的文献
1
The case for etanercept in the management of toxic epidermal necrolysis.依那西普在中毒性表皮坏死松解症治疗中的应用依据
Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug.
2
Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.用于史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及中毒性表皮坏死松解症-史蒂文斯-约翰逊综合征重叠综合征的生物肿瘤坏死因子-α抑制剂：一项研究水平和患者水平的荟萃分析
Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.
3
A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的全身治疗综述
Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.
4
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的当前药物遗传学观点
Front Pharmacol. 2021 Apr 26;12:588063. doi: 10.3389/fphar.2021.588063. eCollection 2021.
5
Survey of Nonprescription Medication and Antibiotic Use in Patients with Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Overlap Syndrome.史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及重叠综合征患者非处方药和抗生素使用情况调查
Antibiotics (Basel). 2018 Feb 1;7(1):11. doi: 10.3390/antibiotics7010011.
6
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的最新观点。
Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176. doi: 10.1007/s12016-017-8654-z.
本文引用的文献
1
Etanercept therapy for toxic epidermal necrolysis.依那西普治疗中毒性表皮坏死松解症。
J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.
2
Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.儿童史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的复发和结局。
Pediatrics. 2011 Oct;128(4):723-8. doi: 10.1542/peds.2010-3322. Epub 2011 Sep 2.
3
Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征：综述。
Crit Care Med. 2011 Jun;39(6):1521-32. doi: 10.1097/CCM.0b013e31821201ed.
4
Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature.非甾体抗炎药的严重皮肤不良反应：文献综述。
Am J Health Syst Pharm. 2010 Feb 1;67(3):206-13. doi: 10.2146/ajhp080603.
5
Etanercept in the treatment of a patient with acute generalized exanthematous pustulosis/toxic epidermal necrolysis: definition of a new model based on translational research.依那西普治疗急性泛发性脓疱性皮病/中毒性表皮坏死松解症患者：基于转化研究的新模型定义
Int J Dermatol. 2009 Aug;48(8):913-4. doi: 10.1111/j.1365-4632.2008.04020.x.
6
Toxic epidermal necrolysis successfully treated with etanercept.用依那西普成功治疗中毒性表皮坏死松解症。
J Dermatol. 2009 Mar;36(3):150-3. doi: 10.1111/j.1346-8138.2009.00616.x.
7
Toxic epidermal necrolysis: 15 years' experience in a Dutch burns centre.中毒性表皮坏死松解症：荷兰一家烧伤中心的15年经验
J Eur Acad Dermatol Venereol. 2007 Jul;21(6):781-8. doi: 10.1111/j.1468-3083.2006.02082.x.
8
A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.
Photodermatol Photoimmunol Photomed. 2005 Apr;21(2):100-2. doi: 10.1111/j.1600-0781.2005.00149.x.
9
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions.中毒性表皮坏死松解症样急性皮肤型红斑狼疮及凋亡性全层表皮松解急性综合征（ASAP）谱：一例报告、概念综述及红斑狼疮水疱大疱性皮肤病变新分类的提议
Lupus. 2004;13(12):941-50. doi: 10.1191/0961203304lu2037sa.
10
Acute vanishing bile duct syndrome after ibuprofen therapy in a child.一名儿童布洛芬治疗后出现急性消失性胆管综合征。
J Pediatr. 2004 Aug;145(2):273-6. doi: 10.1016/j.jpeds.2004.05.027.
Zotero 插件